Browsing: Uncategorized

SHANGHAI, Aug. 6, 2026 /PRNewswire/ — Attovia Therapeutics, a portfolio company of Qiming Venture Partners and clinical-stage biopharmaceutical leader, successfully listed on the Nasdaq on August 5, 2026 Beijing time. Attovia Therapeutics (Nasdaq: ATTO) issued shares at a price of

SHANGHAI, Aug. 6, 2026 /PRNewswire/ — Attovia Therapeutics, a portfolio company of Qiming Venture Partners and clinical-stage biopharmaceutical leader, successfully listed on the Nasdaq on August 5, 2026 Beijing time. Attovia Therapeutics (Nasdaq: ATTO) issued shares at a price of

SHANGHAI, Aug. 6, 2026 /PRNewswire/ — Attovia Therapeutics, a portfolio company of Qiming Venture Partners and clinical-stage biopharmaceutical leader, successfully listed on the Nasdaq on August 5, 2026 Beijing time. Attovia Therapeutics (Nasdaq: ATTO) issued shares at a price of

SHANGHAI, Aug. 6, 2026 /PRNewswire/ — Attovia Therapeutics, a portfolio company of Qiming Venture Partners and clinical-stage biopharmaceutical leader, successfully listed on the Nasdaq on August 5, 2026 Beijing time. Attovia Therapeutics (Nasdaq: ATTO) issued shares at a price of

SHANGHAI, Aug. 6, 2026 /PRNewswire/ — Attovia Therapeutics, a portfolio company of Qiming Venture Partners and clinical-stage biopharmaceutical leader, successfully listed on the Nasdaq on August 5, 2026 Beijing time. Attovia Therapeutics (Nasdaq: ATTO) issued shares at a price of

SHANGHAI, Aug. 6, 2026 /PRNewswire/ — Attovia Therapeutics, a portfolio company of Qiming Venture Partners and clinical-stage biopharmaceutical leader, successfully listed on the Nasdaq on August 5, 2026 Beijing time. Attovia Therapeutics (Nasdaq: ATTO) issued shares at a price of

SHANGHAI, Aug. 6, 2026 /PRNewswire/ — Attovia Therapeutics, a portfolio company of Qiming Venture Partners and clinical-stage biopharmaceutical leader, successfully listed on the Nasdaq on August 5, 2026 Beijing time. Attovia Therapeutics (Nasdaq: ATTO) issued shares at a price of

SHANGHAI, Aug. 6, 2026 /PRNewswire/ — Attovia Therapeutics, a portfolio company of Qiming Venture Partners and clinical-stage biopharmaceutical leader, successfully listed on the Nasdaq on August 5, 2026 Beijing time. Attovia Therapeutics (Nasdaq: ATTO) issued shares at a price of

In a critical safety alert, the U.S. Consumer Product Safety Commission (CPSC) has issued a stern warning against the use of high-powered magnetic-ball toy sets. These products have been implicated in seven fatalities and approximately 2,400 emergency hospital admissions from 2017 to

WaterWipes Introduces New Plastic Free* Wipes in Response to Growing Environmental Concerns Among Parents